Curaleaf Holdings Inc.

Canaccord Genuity acts as Co-Lead Agent and Joint Bookrunner to Curaleaf Holdings Inc. on its US$475 million Debt Financing

Canaccord Genuity is pleased to announce that on December 21, 2021, its client Curaleaf Holdings Inc. (“Curaleaf”), successfully closed its issuance of senior secured notes. In aggregate, the private placement consisted of US$475 million of notes, each note being comprised of US$1,000 aggregate principal amount of 8.00% senior secured notes payable semi-annually, due in 2026. The transaction represents the largest debt financing of any public U.S. cannabis operator.

Curaleaf is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. Curaleaf currently operates in 23 states with 113 dispensaries, 25 cultivation sites, and employs over 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF.

Canaccord Genuity acted as joint bookrunner and co-lead agent to Curaleaf. The Canaccord Genuity team included Dan Daviau and Steve Winokur from Investment Banking and Angus Rogers, Bill Chrumka, Mark Hoogeveen and Justin Ulster from Fixed Income, with key transactional support from Jennifer Webster.